Celltrion
068270.KS
#810
Rank
NZ$54.39 B
Marketcap
NZ$238.53
Share price
-2.13%
Change (1 day)
10.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): NZ$5.65

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$5.80. In 2025 the company made an earnings per share (EPS) of NZ$5.51 an increase over its 2024 EPS that were of NZ$2.09.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.652.61%
2025NZ$5.51163.66%
2024NZ$2.09-53.73%
2023NZ$4.52-2.08%
2022NZ$4.61-11.72%
2021NZ$5.222.03%
2020NZ$5.1282.8%
2019NZ$2.8018.31%
2018NZ$2.37-36.33%
2017NZ$3.72161.25%
2016NZ$1.422.86%
2015NZ$1.3817.84%
2014NZ$1.175.87%
2013NZ$1.11-70.85%
2012NZ$3.81134.09%
2011NZ$1.6343.59%
2010NZ$1.1374.49%
2009NZ$0.65317.8%
2008NZ$0.16-71.7%
2007NZ$0.55